EUR-Lex Access to European Union law
This document is an excerpt from the EUR-Lex website
Document 32009L0153
Commission Directive 2009/153/EC of 30 November 2009 amending Annex I to Council Directive 91/414/EEC as regards the common name and the purity of the active substance hydrolysed proteins (Text with EEA relevance)
Commission Directive 2009/153/EC of 30 November 2009 amending Annex I to Council Directive 91/414/EEC as regards the common name and the purity of the active substance hydrolysed proteins (Text with EEA relevance)
Commission Directive 2009/153/EC of 30 November 2009 amending Annex I to Council Directive 91/414/EEC as regards the common name and the purity of the active substance hydrolysed proteins (Text with EEA relevance)
OJ L 314, 1.12.2009, p. 67–68
(BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
No longer in force, Date of end of validity: 13/06/2011; Implicitly repealed by 32009R1107
|
1.12.2009 |
EN |
Official Journal of the European Union |
L 314/67 |
COMMISSION DIRECTIVE 2009/153/EC
of 30 November 2009
amending Annex I to Council Directive 91/414/EEC as regards the common name and the purity of the active substance hydrolysed proteins
(Text with EEA relevance)
THE COMMISSION OF THE EUROPEAN COMMUNITIES,
Having regard to the Treaty establishing the European Community,
Having regard to Council Directive 91/414/EEC of 15 July 1991 concerning the placing of plant protection products on the market (1), and in particular the second indent of the second subparagraph of Article 6(1) thereof,
Whereas:
|
(1) |
Directive 91/414/EEC was amended by Commission Directive 2008/127/EC (2) to include certain hydrolysed proteins. |
|
(2) |
The rapporteur Member State has received additional information on hydrolysed proteins. It appears that hydrolysed proteins can be originated by many different organic compounds. It is therefore appropriate to refer to the common name and purity specifications, as set out in the review report on hydrolysed proteins. |
|
(3) |
Directive 91/414/EEC should therefore be amended accordingly. |
|
(4) |
The measures provided for in this Directive are in accordance with the opinion of the Standing Committee on the Food Chain and Animal Health, |
HAS ADOPTED THIS DIRECTIVE:
Article 1
Annex I to Directive 91/414/EEC is amended in accordance with the Annex to this Directive.
Article 2
Member States shall adopt and publish, by 28 February 2010 at the latest, the laws, regulations and administrative provisions necessary to comply with this Directive. They shall forthwith communicate to the Commission the text of those provisions and a correlation table between those provisions and this Directive.
They shall apply those provisions from 1 March 2010.
When Member States adopt those provisions, they shall contain a reference to this Directive or be accompanied by such a reference on the occasion of their official publication. Member States shall determine how such reference is to be made.
Article 3
This Directive shall enter into force on the day following its publication in the Official Journal of the European Union.
Article 4
This Directive is addressed to the Member States.
Done at Brussels, 30 November 2009.
For the Commission
Androulla VASSILIOU
Member of the Commission
ANNEX
In Annex I to Directive 91/414/EEC, row No 240 is replaced by the following:
|
No |
Common name, identification numbers |
IUPAC name |
Purity (1) |
Entry into force |
Expiration of inclusion |
Specific provisions |
|
‘240 |
Hydrolysed proteins CAS No: not allocated CIPAC No: not allocated |
Not available |
Review report (SANCO/2615/2008) |
1 September 2009 |
31 August 2019 |
PART A Only uses as attractant may be authorised. Hydrolysed proteins of animal origin must be in compliance with Regulation (EC) No 1774/2002. PART B For the implementation of the uniform principles of Annex VI, the conclusions of the review report on hydrolysed proteins (SANCO/2615/2008) and in particular Appendices I and II thereof, as finalised in the Standing Committee on the Food Chain and Animal Health shall be taken into account. Conditions of use shall include, where appropriate, risk mitigation measures.’ |
(1) Further details on identity and specification of active substances are provided in the review report.